Clinical Study
Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
Table 1
Demographic characteristics of patients at baseline.
| | | Control () | Treatment () |
| | Age (years) | | | | BMI (kg/m2) | | | | Only metabolic syndrome (/%) | 14 (70%) | 14 (70%) | | MetS + type 2 diabetes (/%) | 6 (30%) | 6 (30%) | | Smokers (/%) | 4 (20%) | 4 (20%) | | Treatments | | | | None (/%) | 8 (40%) | 6 (30%) | | Metformin (/%) | 8 (40%) | 8 (40%) | Antihypertensives
(/%) | 12 (60%) | 8 (40%) | | Statins (/%) | 4 (20%) | 5 (25%) | | Fibrates (/%) | 0 (0%) | 2 (10%) | | Other (/%) | 4 (20%) | 5 (25%) |
|
|
